Redhill Biopharma Stock Price History
RDHL Stock | USD 6.74 0.34 5.31% |
Below is the normalized historical share price chart for Redhill Biopharma extending back to January 07, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Redhill Biopharma stands at 6.74, as last reported on the 21st of November, with the highest price reaching 6.79 and the lowest price hitting 6.37 during the day.
If you're considering investing in Redhill Stock, it is important to understand the factors that can impact its price. Redhill Biopharma maintains Sharpe Ratio (i.e., Efficiency) of -0.0705, which implies the firm had a -0.0705% return per unit of risk over the last 3 months. Redhill Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Redhill Biopharma's Risk Adjusted Performance of (0.03), coefficient of variation of (1,926), and Variance of 34.92 to confirm the risk estimate we provide.
At this time, Redhill Biopharma's Common Stock Shares Outstanding is quite stable compared to the past year. Common Stock is expected to rise to about 22.5 M this year, although the value of Total Stockholder Equity will most likely fall to about 2 M. . Price Earnings Ratio is expected to rise to 10.38 this year, although the value of Price To Sales Ratio will most likely fall to 34.49. Redhill Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of January 2013 | 200 Day MA 10.5808 | 50 Day MA 8.5373 | Beta 3.671 |
Redhill |
Sharpe Ratio = -0.0705
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | RDHL |
Estimated Market Risk
4.84 actual daily | 43 57% of assets are more volatile |
Expected Return
-0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Redhill Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Redhill Biopharma by adding Redhill Biopharma to a well-diversified portfolio.
Price Book 134.3516 | Enterprise Value Ebitda 0.3005 | Price Sales 2.2108 | Shares Float 11.1 B | Wall Street Target Price 19 K |
Redhill Biopharma Stock Price History Chart
There are several ways to analyze Redhill Stock price data. The simplest method is using a basic Redhill candlestick price chart, which shows Redhill Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 10, 2024 | 12.18 |
Lowest Price | November 20, 2024 | 6.4 |
Redhill Biopharma November 21, 2024 Stock Price Synopsis
Various analyses of Redhill Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Redhill Stock. It can be used to describe the percentage change in the price of Redhill Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Redhill Stock.Redhill Biopharma Price Daily Balance Of Power | 0.81 | |
Redhill Biopharma Accumulation Distribution | 1,002 | |
Redhill Biopharma Price Action Indicator | 0.33 | |
Redhill Biopharma Price Rate Of Daily Change | 1.05 |
Redhill Biopharma November 21, 2024 Stock Price Analysis
Redhill Stock Price History Data
The price series of Redhill Biopharma for the period between Fri, Aug 23, 2024 and Thu, Nov 21, 2024 has a statistical range of 5.78 with a coefficient of variation of 12.85. The price distribution for the period has arithmetic mean of 8.65. The median price for the last 90 days is 8.36. The company completed stock split (1:25) on 20th of August 2024.Open | High | Low | Close | Volume | ||
11/21/2024 | 6.37 | 6.79 | 6.37 | 6.74 | 16,197 | |
11/20/2024 | 6.88 | 6.88 | 6.35 | 6.40 | 24,507 | |
11/19/2024 | 7.21 | 7.21 | 6.83 | 6.85 | 11,804 | |
11/18/2024 | 7.21 | 7.37 | 6.99 | 6.99 | 11,518 | |
11/15/2024 | 7.05 | 7.30 | 6.70 | 7.29 | 11,707 | |
11/14/2024 | 7.00 | 7.36 | 6.81 | 6.99 | 11,644 | |
11/13/2024 | 7.32 | 7.32 | 7.03 | 7.03 | 8,671 | |
11/12/2024 | 7.75 | 7.75 | 7.04 | 7.18 | 36,668 | |
11/11/2024 | 8.05 | 8.15 | 7.65 | 7.89 | 26,379 | |
11/08/2024 | 8.02 | 8.18 | 8.02 | 8.05 | 8,899 | |
11/07/2024 | 8.22 | 8.29 | 7.98 | 8.16 | 8,272 | |
11/06/2024 | 8.28 | 8.50 | 8.28 | 8.31 | 13,909 | |
11/05/2024 | 8.08 | 8.42 | 7.90 | 8.42 | 11,788 | |
11/04/2024 | 8.07 | 8.14 | 7.91 | 7.95 | 19,348 | |
11/01/2024 | 8.26 | 8.30 | 8.05 | 8.17 | 11,075 | |
10/31/2024 | 8.37 | 8.58 | 8.20 | 8.24 | 6,369 | |
10/30/2024 | 8.01 | 8.35 | 8.01 | 8.34 | 9,127 | |
10/29/2024 | 8.20 | 8.30 | 8.00 | 8.01 | 17,928 | |
10/28/2024 | 8.16 | 8.41 | 8.16 | 8.21 | 24,943 | |
10/25/2024 | 8.32 | 8.32 | 7.99 | 8.20 | 9,569 | |
10/24/2024 | 8.02 | 8.02 | 7.80 | 7.99 | 8,147 | |
10/23/2024 | 8.34 | 8.34 | 8.02 | 8.02 | 10,737 | |
10/22/2024 | 8.70 | 8.90 | 8.28 | 8.34 | 11,166 | |
10/21/2024 | 8.83 | 9.00 | 8.53 | 8.62 | 20,284 | |
10/18/2024 | 8.61 | 8.89 | 8.31 | 8.79 | 14,411 | |
10/17/2024 | 8.34 | 8.40 | 8.16 | 8.21 | 8,194 | |
10/16/2024 | 8.21 | 8.49 | 8.00 | 8.49 | 13,225 | |
10/15/2024 | 8.10 | 8.25 | 7.90 | 8.10 | 18,095 | |
10/14/2024 | 8.03 | 8.05 | 7.91 | 7.98 | 9,476 | |
10/11/2024 | 8.25 | 8.25 | 7.97 | 8.01 | 4,885 | |
10/10/2024 | 8.06 | 8.10 | 7.99 | 8.10 | 4,161 | |
10/09/2024 | 8.00 | 8.26 | 8.00 | 8.07 | 63,503 | |
10/08/2024 | 8.30 | 8.30 | 8.00 | 8.01 | 11,219 | |
10/07/2024 | 8.16 | 8.46 | 8.15 | 8.30 | 11,031 | |
10/04/2024 | 8.00 | 8.50 | 8.00 | 8.50 | 13,008 | |
10/03/2024 | 8.04 | 8.20 | 7.95 | 8.15 | 27,123 | |
10/02/2024 | 8.30 | 8.31 | 7.96 | 8.04 | 17,873 | |
10/01/2024 | 8.66 | 9.05 | 8.30 | 8.30 | 28,666 | |
09/30/2024 | 8.63 | 8.95 | 8.50 | 8.74 | 46,820 | |
09/27/2024 | 9.23 | 9.25 | 8.59 | 8.63 | 31,974 | |
09/26/2024 | 9.45 | 9.59 | 9.07 | 9.32 | 40,184 | |
09/25/2024 | 9.81 | 10.00 | 9.50 | 9.64 | 21,554 | |
09/24/2024 | 9.92 | 10.32 | 9.50 | 9.71 | 24,304 | |
09/23/2024 | 9.55 | 10.50 | 9.53 | 9.92 | 39,372 | |
09/20/2024 | 9.70 | 11.07 | 9.50 | 9.50 | 14,956 | |
09/19/2024 | 9.75 | 9.98 | 9.63 | 9.68 | 19,886 | |
09/18/2024 | 10.15 | 10.25 | 9.75 | 9.75 | 32,670 | |
09/17/2024 | 10.75 | 10.75 | 10.17 | 10.34 | 17,150 | |
09/16/2024 | 11.70 | 11.70 | 10.74 | 10.75 | 30,675 | |
09/13/2024 | 10.75 | 11.65 | 10.75 | 11.01 | 39,804 | |
09/12/2024 | 10.85 | 11.00 | 10.49 | 10.74 | 10,577 | |
09/11/2024 | 12.04 | 12.19 | 10.35 | 10.85 | 74,013 | |
09/10/2024 | 10.30 | 12.50 | 10.23 | 12.18 | 160,513 | |
09/09/2024 | 9.38 | 10.35 | 9.38 | 10.30 | 54,526 | |
09/06/2024 | 9.05 | 9.60 | 8.99 | 9.38 | 69,051 | |
09/05/2024 | 8.67 | 9.27 | 8.36 | 8.95 | 46,274 | |
09/04/2024 | 8.56 | 8.99 | 8.29 | 8.72 | 74,730 | |
09/03/2024 | 8.52 | 9.05 | 8.21 | 8.56 | 51,689 | |
08/30/2024 | 8.63 | 8.83 | 8.36 | 8.50 | 21,440 | |
08/29/2024 | 8.54 | 9.09 | 8.18 | 8.62 | 91,357 | |
08/28/2024 | 7.49 | 8.55 | 7.34 | 8.36 | 121,628 |
About Redhill Biopharma Stock history
Redhill Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Redhill is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Redhill Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Redhill Biopharma stock prices may prove useful in developing a viable investing in Redhill Biopharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 6.5 M | 6.8 M | |
Net Loss | -88 M | -83.6 M |
Redhill Biopharma Stock Technical Analysis
Redhill Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Redhill Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Redhill Biopharma's price direction in advance. Along with the technical and fundamental analysis of Redhill Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Redhill to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.34) | |||
Total Risk Alpha | (0.99) | |||
Treynor Ratio | (1.10) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Redhill Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Redhill Biopharma. If investors know Redhill will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Redhill Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (302.63) | Revenue Per Share 4.733 | Quarterly Revenue Growth (0.28) | Return On Assets (0.45) | Return On Equity (17.09) |
The market value of Redhill Biopharma is measured differently than its book value, which is the value of Redhill that is recorded on the company's balance sheet. Investors also form their own opinion of Redhill Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Redhill Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Redhill Biopharma's market value can be influenced by many factors that don't directly affect Redhill Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Redhill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Redhill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Redhill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.